- Entry
- $1.25
- Now
- $1.23 -1.6%
- Target
- —
- Score
- —
https://preview.redd.it/tdwnmd3eyzeh1.png?width=2067&format=png&auto=webp&s=09d9e60684600225abc3819ba8746001b85b5230 Picked up 11,000 shares at 2.27$ after the news about their FDA approval for Utebzi (tebipenem pivoxil) — Oral antibiotic for complicated urinary tract infections (cUTIs), including pyelonephritis, in adults. Commercialized via GSK partnership. This was a major catalyst and should have double the price but instead it did nothing and has since gone down. This drug alone could generate over 1B in sales. Float: 42.81m shares Short: 2.86m 52 week range: 1.20 - 3.08 July 14, 2026: Major …
— ORIGINAL POST ·
SPRO Spero Therapeutics FDA approval and then drops? Cheaper buyout?
· r/pennystocks
· Jul 23, 2026